Family nutrition program to prevent overweight and obesity in school-age children

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The intervention combines a mobile health (mHealth) application with a multidisciplinary, family-centered program grounded in authoritative parenting and social cognitive theory, delivered to families of schoolchildren in Nacozari de García, Sonora. Participants are recruited from local schools and randomized by school site to receive the family-based intervention or control procedures, with engagement supported through tailored communications and incentives. Outcomes focus on changes in eating patterns, food-related behaviors, and adiposity categories defined by WHO z-scores for BMI and height-for-age. The protocol excludes children or caregivers with active medical conditions requiring treatment, and requires family access to a smartphone with internet and camera.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Families of children between 5 and 9 years old.
* Children without any medical or nutritional treatment for obesity.
* Children classified as normal weight, overweight, or obese based on WHO (Z-score: height for age and BMI for age).
* Offspring of mothers aged between 18 and 45 years at delivery.
* Term infants from normoevolutive pregnancies without maternal comorbidities.
* Families who have a cell phone with internet access and an installed camera.

Exclusion Criteria:

* Children who are currently suffering from a pathology that requires medication or special treatment
* Mothers/Fathers/Guardians who are currently suffering from a pathology that requires medication or special treatment.
* Children who have a physical/mental impairment to perform physical activities.
* Children from surrogate mothers who have presented at least 2 of the 11 DSM-5 criteria for substance use disorder (alcohol, tobacco, cannabis, or other illegal drugs) before or during the participating child's gestation.
* Children from multiple pregnancies.
* Parents who do not own a smartphone compatible with the app will be excluded from this study (i.e., version 5.0 or higher for Android).

Where it's running

• "El globo" and "Servicios de Salud Lomas Altas"
  México, Sonora, Mexico Recruiting

Study contacts

• Principal investigator: Claudia Tovar-Palacio, Ph.D. — Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
• Study coordinator: Claudia Tovar-Palacio, Ph.D.
• Email: claudia.tovarp@incmnsz.mx
• Phone: +52 5585341831

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Weekly berobenatide for knee osteoarthritis in adults who are overweight or obese

  This study tests whether weekly berobenatide helps reduce knee pain and improve function, while also affecting body weight, in adults with knee osteoarthritis who are overweight or obese (with or without type 2 diabetes).

  Recruiting Phase 3 Pfizer · Birmingham, Alabama and 3 other locations · NCT07915609

• Berobenatide in adults with sleep apnea and obesity who don’t use a PAP machine

  This study tests berobenatide versus placebo in adults with moderate-to-severe obstructive sleep apnea and overweight or obesity who are not using PAP therapy.

  Recruiting at 3 sites Phase 3 Pfizer · Cullman, Alabama and 3 other locations · NCT07881757

• Berobenatide: how it enters the blood after different delivery methods in adults with overweight or obesity

  This study tests a single dose of Berobenatide to see how it behaves in the body when given in different delivery forms to adults with overweight or obesity.

  Recruiting Phase 1 Pfizer · Anaheim, California · NCT07876531

• Switching to a monthly dose of Berobenatide to help keep weight off after weight loss with semaglutide or tirzepatide

  This study tests whether switching to a monthly berobenatide shot can help adults who have overweight or obesity and have already lost weight using semaglutide or tirzepatide to keep the weight off.

  Recruiting at 18 sites Phase 3 Pfizer · Birmingham, Alabama and 25 other locations · NCT07845500

• Berobenatide in adults with sleep apnea and obesity using a PAP machine

  This study tests berobenatide vs. placebo in adults with moderate to severe obstructive sleep apnea and overweight/obesity who use a PAP device.

  Recruiting at 6 sites Phase 3 Pfizer · Cullman, Alabama and 7 other locations · NCT07823608

• Body- or Mind-based regulation in women with overweight or obesity

  This study tests whether a body-based regulation program or a mind-based regulation program helps women with overweight or obesity improve heart rate regulation and emotional eating.

  Recruiting Pamukkale University · Denizli · NCT07738263

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.